• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/10

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

10 Cards in this Set

  • Front
  • Back
New York Heart Association functional classification of heart failure
I - cardiac disease, but no symptoms, no limitation on ordinary physical activity

II - mild symptoms and slight limitation during ordinary activity

III - marked limitation in activity due to symptoms, even during less-than-ordinary activity. comfortable only at rest

IV - severe limitations, symptoms even at rest, mostly bed bound
diagnostic factors
-presence of risk factors
-dyspnoea
-neck vein distenstion
-S3 gallop
-cardiomegaly
-crepitations
-oedema
risk factors for heart failure
-history of MI
-diabetes
-age
-male
-LV dysfunction
-cocaine abuse
-renal insufficiency
-valvular heart disease
-sleep apnoea

elevated - TNF alpha, CRP, natriuretic peptides, IL-6
decreased - IGF-1
diagnostic tests for heart failure
ECHO

ECG

CXR

BNP, NT-pro-BNP (N-terminal pro BNP) if high (>400ng/L) indicates abnormal LV funtion; if low (<100ng/L) rules out decompensated heart failure and indicates pulmonary cause


FBC - amaemia and raised WCC are risk factors

U&E - for baseline

creatine, blood urea nitrogen - reflects tissue perfusion

blood glucose - diabetes risk factor

LFT - reflects abnormal congestion

blood lipids - decreasing in end stage heart failure
lifestyle changes to make with heart failure
reduce salt intake

fluid restriction

continuous monitoring
main drugs used to treat heart failure
-diuretics
-vasodilators
-intropic agents
-ACE-i
-beta blockers
-angiotensin II receptor blockers
-aldosterone receptor antagonists
tell me more about

-diuretics...

-vasodilators
-intropic agents
-ACE-i
-beta blockers
-angiotensin II receptor blockers
-aldosterone receptor antagonists
-loop diuretics

eg furosemide

short duration of action (cf thiazides)

inhibits reabsorption of Na+ and Cl- in THICK ASCENDING LIMB OF THE LOOP OF HENLE
thereby preventing the generation of HYPERTONIC RENAL MEDULLA
water has less of an OSMOTIC DRIVING FORCE to leave the COLLECTING DUCT
increased urine production

enhances Ca++ loss (cf thiazides which reduce Ca++ loss)

side effects
-electrolyte imbalance
-ototoxicity (rare)
tell me more about

-diuretics
-vasodilators

-intropic agents....

-ACE-i
-beta blockers
-angiotensin II receptor blockers
-aldosterone receptor antagonists
eg digoxin

increases SV, ejection fraction
decreases heart rate

side effects
-nausea, vomiting, diarrhoea
tell me more about

-diuretics
-vasodilators
-intropic agents
-ACE-i
-beta blockers
-angiotensin II receptor blockers

-aldosterone receptor antagonists...
eg spironolactone
more invasive option for heart failure treatment
implantable cardiac defibrilator (ICD) - if no LBBB

biventricular pacemaker - if there is LBBB

left ventricular assist device (LVAD)

transplantation

stem cells/myoblasts